Cilostazol is associated with improved outcomes after peripheral endovascular interventions Courtney J. Warner, MD, MS, Spencer W. Greaves, MPH, Robin J. Larson, MD, MPH, David H. Stone, MD, Richard J. Powell, MD, Daniel B. Walsh, MD, Philip P. Goodney, MD, MS Journal of Vascular Surgery Volume 59, Issue 6, Pages 1607-1614 (June 2014) DOI: 10.1016/j.jvs.2013.11.096 Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 2 Newcastle-Ottawa quality assessment scale. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 3 Cochrane risk-of-bias tool. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 4 Restenosis after peripheral vascular intervention (PVI). RCT, Randomized controlled trial. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 5 Forest plot of main outcomes. CI, Confidence interval. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions
Fig 6 Forest plot of mortality outcomes. CI, Confidence interval; RCT, randomized controlled trial. Journal of Vascular Surgery 2014 59, 1607-1614DOI: (10.1016/j.jvs.2013.11.096) Copyright © 2014 Society for Vascular Surgery Terms and Conditions